OTCMKTS:APHQF - Aphria Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.00
+0.30 (1.20%)

This chart shows the closing price for APHQF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Aphria Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for APHQF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for APHQF

Analyst Price Target is $0.00
This price target is based on 0 analysts offering 12 month price targets for Aphria in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.

This chart shows the closing price for APHQF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Aphria. This rating has held steady since October 2019, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/17/2018ScotiabankInitiated CoverageBuy
8/10/2017Canaccord GenuitySet Price TargetBuy$7.00
(Data available from 7/23/2016 forward)

Aphria

Aphria, Inc. engages in the production and supply of medical cannabis. It operates through the following segments: Cannabis Operations, Distribution Operations, and Business Under Development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution Under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $11.58
Low: $11.57
High: $11.93

52 Week Range

Now: N/A

Volume

1,873,800 shs

Average Volume

1,333,435 shs

Market Capitalization

$2.89 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Aphria?

The following sell-side analysts have issued stock ratings on Aphria in the last twelve months:
View the latest analyst ratings for APHQF.

What is the current price target for Aphria?

0 Wall Street analysts have set twelve-month price targets for Aphria in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Aphria in the next year.
View the latest price targets for APHQF.

What is the current consensus analyst rating for Aphria?

Aphria currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for APHQF.

What other companies compete with Aphria?

How do I contact Aphria's investor relations team?

The company's listed phone number is (844) 427-4742.